Elevated Osteopontin Levels in Metastatic Melanoma Correlate with Epigenetic Silencing of Breast Cancer Metastasis Suppressor 1

Publisher： Karger

E-ISSN： 1423-0232|78|1|75-86

ISSN： 0030-2414

Source： Oncology, Vol.78, Iss.1, 2010-03, pp. : 75-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epigenetic silencing of CHD5, a novel tumor‐suppressor gene, occurs in early colorectal cancer stages

By  

CANCER, Vol. 120, Iss. 2, 2014-01 ,pp. : 172-180

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pigmented skin metastasis of breast cancer showing dermoscopic features of malignant melanoma

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 5, 2015-05 ,pp. : 1034-1036

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metastasis suppressor NME1 regulates melanoma cell morphology, self‐adhesion and motility via induction of fibronectin expression

By  

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 24, Iss. 6, 2015-06 ,pp. : 455-461

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum S100B Levels Correlate with Clinical Benefit in a Metastatic Melanoma Patient Treated by CTLA-4 Blockade: A Case Report

By  

Oncology Research and Treatment, Vol. 36, Iss. 10, 2013-09 ,pp. : 578-581

Karger

Access to resources Recommend Favorite

Implications of Different CA 15-3 Levels according to Breast Cancer Subtype at Initial Diagnosis of Recurrent or Metastatic Breast Cancer

By  

Oncology, Vol. 82, Iss. 3, 2012-03 ,pp. : 180-187

Karger

Access to resources Recommend Favorite